CD14+HLA-DRlow/ expression: A novel prognostic factor in chronic lymphocytic leukemia

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1167-1172

Spandidos Publications

Access to resources Recommend Favorite

Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia

By Alonci A.  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1336-1339

Humana Press, Inc

Access to resources Recommend Favorite

Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

By Ogura Michinori   Hatake Kiyohiko   Tobinai Kensei   Uchida Toshiki   Suzuki Tatsuya   Terui Yasuhito   Yokoyama Masahiro   Maruyama Dai   Mori Masakazu   Jewell Roxanne C.   Katsura Koichi   Hotta Tomomitsu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 5, 2013-05 ,pp. : 466-475

Oxford University Press

Access to resources Recommend Favorite

Increased Frequency of CD8⁺ and CD4⁺ Regulatory T Cells in Chronic Lymphocytic Leukemia: Association with Disease Progression

By Jadidi-Niaragh Farhad   Yousefi Mehdi   Memarian Ali   Hojjat-Farsangi Mohammad   Khoshnoodi Jalal   Razavi Seyed Mohsen   Jeddi-Tehrani Mahmood   Shokri Fazel  

Cancer Investigation, Vol. 31, Iss. 2, 2013-02 ,pp. : 121-131

Informa Healthcare

Access to resources Recommend Favorite

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

By Cavalli-Björkman Nina   Ösby Eva   Lundin Jeanette   Kalin Mats   Österborg Anders   Gruber Astrid  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite